PROPHYLAXIS OF EXERCISE-INDUCED ASTHMA WITH INHALED FORMOTEROL, A LONG-ACTING BETA-2-ADRENERGIC AGONIST

被引：27
|
作者：
MCALPINE, LG
THOMSON, NC
机构：
[1] Department of Respiratory Medicine, Western Infirmary, Glasgow
来源：
RESPIRATORY MEDICINE | 1990年 / 84卷 / 04期
关键词：
D O I：
10.1016/S0954-6111(08)80056-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The prophylaxis of exercise-induced asthma with inhaled formoterol (12 μg) was compared with inhaled salbutamol (200 μg) and placebo in 12 patients with atopic asthma. Both drugs produced equal bronchodilation 2 and 4 h after administration. Both drugs protected equally against exercise-induced bronchoconstriction 2 h after administration; at 4 h, formoterol gave undiminished protection from that seen at 2 h while salbutamol was no more effective than placebo. © 1990, Baillière Tindall. All rights reserved.
引用
收藏
页码：293 / 295
页数：3
相关论文
共 50 条
  • [41] Serious Asthma Outcomes and Asthma Exacerbations with Maintenance on Inhaled Corticosteroid (Mometasone Furoate)/Long-Acting Beta Agonist (Formoterol) Combination Compared to Step-Down to Mometasone Monotherapy
    Weinstein, C. L. J.
    Gates, D.
    Ryan, N.
    Zhang, X.
    Shekar, T.
    Lane, S. J.
    Agache, I. O.
    Nathan, R. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [42] Asthma challenges: the place of inhaled long-acting beta-agonists
    Tovey, David
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (04):
  • [43] The addition of long-acting beta-agonists to inhaled corticosteroids in asthma
    Sears, Malcolm R.
    CURRENT OPINION IN PULMONARY MEDICINE, 2011, 17 (01) : 23 - 28
  • [44] Long-acting β2 agonist without concomitant inhaled corticosteroids in children with asthma in primary care
    Engelkes, Marjolein
    Janssens, Hettie
    de Jongste, Johan
    Sturkenboom, Miriam
    Verhamme, Katia
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [45] Long-Acting β2 Agonist Without Concomitant Inhaled Corticosteroids in Children with Asthma in Primary Care
    Engelkes, Marjolein
    Janssens, Hettie M.
    de Jongste, Johan C.
    Sturkenboom, Miriam C. J. M.
    Verhamme, Katia M. C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 152 - 153
  • [46] Pharmacogenetics of inhaled long-acting beta2-agonists in asthma: A systematic review
    Slob, Elise M. A.
    Vijverberg, Susanne J. H.
    Palmer, Colin N. A.
    Zazuli, Zulfan
    Farzan, Niloufar
    Oliveri, Nadia M. B.
    Pijnenburg, Marielle W.
    Koppelman, Gerard H.
    Maitland-van der Zee, Anke H.
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2018, 29 (07) : 705 - 714
  • [47] Combination inhaled corticosteroid and long-acting β2-agonist use and severe asthma exacerbations
    Pedersen, Soren
    O'Byrne, Paul M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (05) : 1280 - 1281
  • [48] Differential effects of maintenance long-acting β-agonist and inhaled corticosteroid on asthma control and asthma exacerbations
    Gibson, Peter G.
    Powell, Heather
    Ducharme, Francine M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (02) : 344 - 350
  • [49] CAPTAIN: Effects of Adding the Long-Acting Muscarinic Antagonist Umeclidinium to Inhaled Corticosteroid/Long-Acting Beta2-Agonist Therapy on Symptoms in Patients with Inadequately Controlled Asthma
    Gardiner, F.
    Pizzichini, E.
    Pavord, I
    Brusselle, G.
    Oppenheimer, J.
    Kerstjens, H.
    Papi, A.
    Inoue, H.
    Tabberer, M.
    Fowler, A.
    Slade, D.
    Bailes, Z.
    Barnes, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [50] PROTECTIVE EFFECT AND DURATION OF ACTION OF INHALED FORMOTEROL AND SALBUTAMOL ON EXERCISE-INDUCED ASTHMA IN CHILDREN
    HENRIKSEN, JM
    AGERTOFT, L
    PEDERSEN, S
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 89 (06) : 1176 - 1182
12345